CAR T-cell therapy involves collecting a patient’s blood, extracting the T cells within the blood, and returning the remaining blood back into the body, a process called leukapheresis.
Sajida Nasser, PharmD candidate
Advertisement
Articles by Sajida Nasser, PharmD candidate
Advertisement
Latest Updated Articles
CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma and Acute Lymphoblastic LeukemiaPublished: August 25th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
FDA Approves First At-Home Treatment Device for Depression
5
